VIR Vir Biotechnology, Inc.
Nasdaq · SEC CIK 1706431 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $21.00M 38 sales by 10 insiders
- Filings on record
- 298 since 2021-07-06, latest 2026-08-12 14:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| SATO VICKI L | Dir | — | $1.73M |
| De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| Sabatini Brent | SVP, CAO | — | $113.1K |
| O'Byrne Jason | EVP, CFO | — | $68.9K |
| Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| Napolitano Janet | Dir | — | $30.2K |
Transactions 390
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-01-06 | 2022-01-05 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 97.8K | +5% | +$7,650 |
| DM | 2022-01-06 | 2022-01-05 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $37.19 | -5,000 | 92.8K | -5% | -$186.0K |
| D | 2021-12-30 | 2021-12-28 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $39.95 | -1,375 | 107.7K | -1% | -$54.9K |
| D | 2021-12-30 | 2021-12-28 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| M | 2021-12-22 | 2021-12-20 | VIR | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | +61.2K | 116.1K | +112% | $0 |
| MI | 2021-12-22 | 2021-12-20 | VIR | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | -1.75M | 10.68M | -14% | $0 |
| MI | 2021-12-22 | 2021-12-20 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -1.75M | 10.68M | -14% | $0 |
| 2021-12-22 | 2021-12-20 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +102.0K | 244.2K | +72% | $0 | |
| I | 2021-12-22 | 2021-12-20 | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $52.73 | -400.0K | 22.22M | -2% | -$21.09M |
| M | 2021-12-21 | 2021-12-20 | VIR | SATO VICKI L | Dir | S - Sale | $54.53 | -15.2K | 1.55M | -1.0% | -$827.5K |
| DM | 2021-12-17 | 2021-12-15 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $50.72 | -5,000 | 96.1K | -5% | -$253.6K |
| D | 2021-12-17 | 2021-12-15 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 97.8K | +5% | +$7,650 |
| DM | 2021-12-16 | 2021-12-14+ | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +4,125 | 110.5K | +4% | +$6,311 |
| DM | 2021-12-16 | 2021-12-14+ | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $48.63 | -4,125 | 107.7K | -4% | -$200.6K |
| M | 2021-12-03 | 2021-12-01 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $43.45 | -7,500 | 94.9K | -7% | -$325.8K |
| D | 2021-12-02 | 2021-11-30 | VIR | Napolitano Janet | Dir | M - OptEx | $41.64 | +1,435 | 4,809 | +43% | +$59.8K |
| D | 2021-12-02 | 2021-11-30 | VIR | Napolitano Janet | Dir | S - Sale+OE | $46.25 | -1,435 | 3,374 | -30% | -$66.4K |
| D | 2021-12-02 | 2021-11-30 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +15.1K | 122.8K | +14% | +$23.1K |
| DM | 2021-12-02 | 2021-11-30 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $49.60 | -15.1K | 121.5K | -11% | -$750.2K |
| D | 2021-12-02 | 2021-11-30 | VIR | Rice Steven J. | Chief Administrative Off | M - OptEx | $12.76 | +10.0K | 30.6K | +49% | +$127.6K |
| D | 2021-12-02 | 2021-11-30 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale+OE | $50.00 | -10.0K | 20.6K | -33% | -$500.0K |
| MI | 2021-12-01 | 2021-11-29 | VIR | BYBEE CLINTON | 10% | J - Other | $0.00 | -500.0K | 11.67M | -4% | $0 |
| M | 2021-12-01 | 2021-11-29 | VIR | BYBEE CLINTON | 10% | J - Other | $0.00 | +17.5K | 70.4K | +33% | $0 |
| MI | 2021-12-01 | 2021-11-29 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -500.0K | 9.00M | -5% | $0 |
| 2021-12-01 | 2021-11-29 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +29.2K | 142.1K | +26% | $0 | |
| I | 2021-12-01 | 2021-11-29 | VIR | HANLY ANN M. | CTO | P - Purchase | $43.39 | +11.52 | 11.52 | New | +$499.85 |
| 2021-11-30 | 2021-11-26 | VIR | SATO VICKI L | Dir | S - Sale | $36.80 | -15.2K | 1.57M | -1.0% | -$558.4K | |
| M | 2021-11-24 | 2021-11-22 | VIR | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | +17.5K | 18.7K | +1,492% | $0 |
| MI | 2021-11-24 | 2021-11-22 | VIR | ARCH Venture Partners IX, L.P. | 10% | J - Other | $0.00 | -500.0K | 9.22M | -5% | $0 |
| 2021-11-24 | 2021-11-22 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +29.2K | 113.0K | +35% | $0 | |
| MI | 2021-11-24 | 2021-11-22 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -500.0K | 9.22M | -5% | $0 |
| D | 2021-11-19 | 2021-11-17 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $5.18 | +5,000 | 105.3K | +5% | +$25.9K |
| DM | 2021-11-19 | 2021-11-17 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $35.85 | -5,000 | 100.7K | -5% | -$179.2K |
| D | 2021-11-18 | 2021-11-16 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-11-18 | 2021-11-16 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $32.67 | -1,375 | 107.7K | -1% | -$44.9K |
| D | 2021-11-04 | 2021-11-03 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $36.47 | -5,000 | 100.3K | -5% | -$182.3K |
| D | 2021-11-04 | 2021-11-03 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $5.18 | +5,000 | 105.3K | +5% | +$25.9K |
| D | 2021-11-03 | 2021-11-02 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-11-03 | 2021-11-02 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $36.94 | -1,375 | 107.7K | -1% | -$50.8K |
| 2021-10-22 | 2021-10-20 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $39.65 | -4,000 | 100.3K | -4% | -$158.6K | |
| D | 2021-10-21 | 2021-10-19 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-10-21 | 2021-10-19 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $38.87 | -1,375 | 107.7K | -1% | -$53.4K |
| M | 2021-10-20 | 2021-10-19 | VIR | SATO VICKI L | Dir | S - Sale | $39.56 | -15.2K | 1.59M | -0.9% | -$600.3K |
| 2021-10-07 | 2021-10-06 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $34.56 | -5,000 | 104.3K | -5% | -$172.8K | |
| D | 2021-10-06 | 2021-10-05 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 109.1K | +1% | +$2,104 |
| D | 2021-10-06 | 2021-10-05 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $33.75 | -1,375 | 107.7K | -1% | -$46.4K |
| D | 2021-09-29 | 2021-09-27 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $0.86 | +5,000 | 109.3K | +5% | +$4,300 |
| D | 2021-09-24 | 2021-09-22 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +8,000 | 107.7K | +8% | +$12.2K |
| D | 2021-09-22 | 2021-09-21 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +4,125 | 103.8K | +4% | +$6,311 |
| D | 2021-09-22 | 2021-09-21 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $50.00 | -4,125 | 99.7K | -4% | -$206.2K |
| M | 2021-09-21 | 2021-09-17 | VIR | SATO VICKI L | Dir | S - Sale | $52.48 | -15.2K | 1.60M | -0.9% | -$796.3K |
| M | 2021-09-17 | 2021-09-15 | VIR | Pang Phillip | Chief Medical Off | S - Sale | $49.69 | -5,000 | 104.3K | -5% | -$248.5K |
| DM | 2021-09-09 | 2021-09-07 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $49.67 | -4,125 | 102.5K | -4% | -$204.9K |
| D | 2021-09-09 | 2021-09-07 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +4,125 | 103.8K | +4% | +$6,311 |
| DM | 2021-09-02 | 2021-09-01 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $49.58 | -5,000 | 112.4K | -4% | -$247.9K |
| D | 2021-09-02 | 2021-09-01 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 114.3K | +5% | +$7,650 |
| D | 2021-08-31 | 2021-08-30 | VIR | Napolitano Janet | Dir | M - OptEx | $41.64 | +1,435 | 4,809 | +43% | +$59.8K |
| D | 2021-08-31 | 2021-08-30 | VIR | Napolitano Janet | Dir | S - Sale+OE | $51.15 | -1,435 | 3,374 | -30% | -$73.4K |
| D | 2021-08-26 | 2021-08-25 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $50.00 | -2,750 | 99.7K | -3% | -$137.5K |
| D | 2021-08-26 | 2021-08-25 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +2,750 | 102.5K | +3% | +$4,208 |
| D | 2021-08-25 | 2021-08-24 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
| D | 2021-08-25 | 2021-08-24 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $48.00 | -1,375 | 99.7K | -1% | -$66.0K |
| D | 2021-08-24 | 2021-08-23 | VIR | Rice Steven J. | Chief Administrative Off | M - OptEx | $12.76 | +10.0K | 30.0K | +50% | +$127.6K |
| D | 2021-08-24 | 2021-08-23 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale+OE | $50.00 | -10.0K | 20.0K | -33% | -$500.0K |
| D | 2021-08-24 | 2021-08-23 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +13.8K | 113.5K | +14% | +$21.0K |
| D | 2021-08-24 | 2021-08-23 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $50.00 | -13.8K | 99.7K | -12% | -$687.5K |
| M | 2021-08-23 | 2021-08-19 | VIR | SATO VICKI L | Dir | S - Sale | $45.05 | -15.2K | 1.61M | -0.9% | -$683.6K |
| D | 2021-08-20 | 2021-08-18 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.53 | +5,000 | 114.3K | +5% | +$7,650 |
| D | 2021-08-20 | 2021-08-18 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $42.23 | -5,000 | 109.3K | -4% | -$211.1K |
| D | 2021-08-11 | 2021-08-10 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
| D | 2021-08-11 | 2021-08-10 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $41.00 | -1,375 | 99.7K | -1% | -$56.4K |
| D | 2021-08-05 | 2021-08-04 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $5.18 | +5,000 | 114.3K | +5% | +$25.9K |
| D | 2021-08-05 | 2021-08-04 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $34.92 | -5,000 | 109.3K | -4% | -$174.6K |
| 2021-08-02 | 2021-07-01 | VIR | MORE ROBERT J | Dir | A - Grant | $43.53 | +1,671 | 47.7K | +4% | +$72.7K | |
| M | 2021-08-02 | 2021-07-29 | VIR | MORE ROBERT J | Dir | S - Sale | $36.82 | -11.7K | 36.0K | -24% | -$429.7K |
| D | 2021-07-28 | 2021-07-27 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
| D | 2021-07-28 | 2021-07-27 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $36.72 | -1,375 | 99.7K | -1% | -$50.5K |
| D | 2021-07-23 | 2021-07-21 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $37.44 | -4,630 | 109.3K | -4% | -$173.3K |
| D | 2021-07-23 | 2021-07-21 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $1.58 | +4,630 | 113.9K | +4% | +$7,315 |
| M | 2021-07-20 | 2021-07-19 | VIR | SATO VICKI L | Dir | S - Sale | $37.20 | -15.2K | 1.63M | -0.9% | -$564.5K |
| 2021-07-19 | 2021-07-15 | VIR | MORE ROBERT J | Dir | S - Sale | $35.56 | -11.7K | 46.0K | -20% | -$415.0K | |
| D | 2021-07-14 | 2021-07-13 | VIR | Virgin Herbert | EVP, CSO, Research | S - Sale+OE | $36.72 | -1,375 | 99.7K | -1% | -$50.5K |
| D | 2021-07-14 | 2021-07-13 | VIR | Virgin Herbert | EVP, CSO, Research | M - OptEx | $1.53 | +1,375 | 101.1K | +1% | +$2,104 |
| DM | 2021-07-08 | 2021-07-07 | VIR | Pang Phillip | Chief Medical Off | S - Sale+OE | $40.38 | -5,000 | 110.8K | -4% | -$201.9K |
| D | 2021-07-08 | 2021-07-07 | VIR | Pang Phillip | Chief Medical Off | M - OptEx | $5.18 | +5,000 | 114.3K | +5% | +$25.9K |
| M | 2021-07-06 | 2021-07-01 | VIR | MORE ROBERT J | Dir | S - Sale | $44.93 | -11.7K | 57.7K | -17% | -$524.3K |
| M | 2021-07-06 | 2021-07-01 | VIR | ARCH Venture Partners IX, LLC | 10% | J - Other | $0.00 | +33.4K | 44.2K | +309% | $0 |
| MI | 2021-07-06 | 2021-07-01 | VIR | ARCH Venture Partners IX, LLC | 10% | J - Other | $0.00 | -4.00M | 9.44M | -30% | $0 |
| 2021-07-06 | 2021-07-01 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | +47.9K | 83.8K | +133% | $0 | |
| MI | 2021-07-06 | 2021-07-01 | VIR | NELSEN ROBERT | Dir, 10% | J - Other | $0.00 | -4.00M | 12.23M | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations